蛋白质组学揭示白癜风治疗中皮肤色素恢复的生物学机制
本研究对30例开始标准治疗的白癜风患者,在基线和治疗3个月时采集血浆和水疱液,用Somascan检测5080种蛋白质。发现5种蛋白与复色相关,涉及免疫抑制和刺激黑素生成,NACHT、LRR和PYD结构域蛋白1炎症小体通路富集,提示治疗诱导复色并非简单逆转病变皮肤至非病变状态。
要点
- 基线水疱液中T细胞免疫球蛋白和黏蛋白结构域1、三叶因子3及NACHT、LRR和PYD结构域蛋白1较高与复色相关。
- 治疗中血浆角蛋白II型细胞骨架5升高与复色相关。
- 复色相关蛋白与通路不同于既往病变与非病变皮肤的差异,提示黑素细胞特异性通路差异表达。
核心结论
- 治疗诱导的白癜风复色涉及免疫抑制和刺激黑素生成等过程,并非简单逆转病变皮肤至非病变状态。
研究设计与样本
- 研究纳入30例开始标准治疗的白癜风患者,采集基线和治疗3个月时的血浆及水疱液样本。
- 使用Somascan对5080种蛋白质进行大规模蛋白质组学检测。
主要发现
- 分析治疗中变化和未变化的蛋白质,发现5种蛋白质与复色相关。
- 基线水疱液中T细胞免疫球蛋白和黏蛋白结构域1、三叶因子3及NACHT、LRR和PYD结构域蛋白1较高与复色相关。
- 治疗中血浆角蛋白II型细胞骨架5升高与复色相关。
- T细胞免疫球蛋白和黏蛋白结构域1和三叶因子3具有免疫抑制作用,NACHT、LRR和PYD结构域蛋白1和角蛋白II型细胞骨架5可刺激黑素生成。
- NACHT、LRR和PYD结构域蛋白1炎症小体通路在这些蛋白质中富集。
关键数值与推荐
- 复色相关蛋白和通路与既往病变与非病变皮肤的差异不同,表明黑素细胞特异性通路存在差异表达。
临床怎么用
- 这些发现增进了对白癜风复色的理解,可能指导未来治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Vitiligo is an autoimmune disease characterized by depigmented skin lesions, caused by autoreactive-CD8-T-cells inducing melanocyte apoptosis. Effective treatment is challenging due to limited understanding of the processes underlying skin repigmentation. This study aimed to identify these processes using proteomics. Plasma and skin blister-fluid samples from 30 patients with vitiligo starting standard-of-care treatment were analyzed. A large proteomic screen of 5080 proteins was measured with Somascan on samples collected at baseline and at 3 months of treatment. Analyses of proteins that changed and did not change under treatment, revealed 5 proteins associated with repigmentation. Higher baseline levels of T-cell immunoglobulin and mucin domain 1, trefoil factor 3, and NACHT, LRR and PYD domains-containing protein 1 in blister-fluid and an increase of keratin type II cytoskeletal 5 in plasma under treatment, were associated with repigmentation. T-cell immunoglobulin and mucin domain 1 and trefoil factor 3 have immunosuppressive effects, while NACHT, LRR and PYD domains-containing protein 1 and keratin type II cytoskeletal 5 can stimulate melanogenesis. The NACHT, LRR and PYD domains-containing protein 1-inflammasome pathway was enriched in these proteins. These proteins and pathways were distinct from the previously identified differences between lesional and non-lesional skin, indicating differential expression of melanocyte-specific pathways. This suggests that treatment-induced repigmentation in vitiligo involves processes other than simply reversing lesional skin to a non-lesional state. These findings enhance the understanding of repigmentation in vitiligo and could guide future therapeutic strategies.
引用
- Holtappels E, van Uden NOP, Chielie S, et al. Revealing biological mechanisms of skin pigment recovery during treatment in vitiligo patients: A proteomic analysis. J Invest Dermatol. 2026. PMID: 42235790. doi:10.1016/j.jid.2026.05.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。